Sigma-Aldrich Investor Relations Sigma-Aldrich Investor Home Home Sigma-Aldrich home page



Investor Relations

Corporate Profile

Sigma-Aldrich, a leading Life Science and Technology company focused on enhancing human health and safety, manufactures and distributes 230,000 chemicals, biochemicals and other essential products and 40,000 equipment products to more than 1.4 million customers globally in research and applied labs as well as in industrial and commercial markets.  With three distinct business units – Research, Applied and SAFC Commercial – Sigma-Aldrich is committed to enabling science to improve the quality of life.  The Company operates in 37 countries, has approximately 9,000 employees worldwide and had sales of $2.7 billion in 2013.  For more information about Sigma-Aldrich, please visit its website at www.sigma-aldrich.com.

Recent Releases

Feb 24, 2015
Cerilliant Introduces Certified Spiking Solutions® of Tryptamines

Feb 18, 2015
Sigma® Life Science Releases Next-Gen Sequencing Oligos

Feb 12, 2015
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Full-Year 2014 Sales Of $2.79 Billion And Record Adjusted Diluted EPS Of $4.37. Reports Q4 2014 Adjusted Diluted EPS Of $1.14 And Organic Sales Growth Of 7%. Declares $0.23 Per Share Quarterly Dividend.

View all releases »


 

© 2015 Sigma-Aldrich Co. Reproduction forbidden without permission.
Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc. Best viewed in IE5 or higher